Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.verified

4536.T

Price:

$1930

Market Cap:

$620.84B

Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It pro...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2001-01-04

Stock Exchange

JPX

Ticker

4536.T

The PE Ratio as of June 2026 (TTM) for Santen Pharmaceutical Co., Ltd. (4536.T) is 16.96

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 16.96. This represents a change of 1.84% compared to the average of 16.65 of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (4536.T) Historical PE Ratio (quarterly & annually)

How has 4536.T PE Ratio performed in the past?

The mean historical PE Ratio of Santen Pharmaceutical Co., Ltd. over the last ten years is 20.59. The current 16.96 PE Ratio has changed 8.14% with respect to the historical average. Over the past ten years (40 quarters), 4536.T's PE Ratio was at its highest in in the March 2024 quarter at 4.30K. The PE Ratio was at its lowest in in the March 2021 quarter at -13.02.

Quarterly (TTM)
Annual

Average

20.59

Median

19.66

Minimum

-29.29

Maximum

65.34

Santen Pharmaceutical Co., Ltd. (4536.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 132.06%

Maximum Annual PE Ratio = 65.34

Minimum Annual Increase = -262.51%

Minimum Annual PE Ratio = -29.29

Quarterly (TTM)
Annual
YearPE RatioChange
202615.6514.81%
202513.63-30.27%
202419.55-166.77%
2023-29.29-262.51%
202218.02-72.42%
202165.34108.08%
202031.4047.31%
201921.327.80%
201819.77-35.08%
201730.46132.06%

Santen Pharmaceutical Co., Ltd. (4536.T) Average PE Ratio

How has 4536.T PE Ratio performed in the past?

The current PE Ratio of Santen Pharmaceutical Co., Ltd. (4536.T) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

16.28

5-year avg

7.52

10-year avg

20.59

Santen Pharmaceutical Co., Ltd. (4536.T) PE Ratio vs. Peers

How is 4536.T’s PE Ratio compared to its peers?

Santen Pharmaceutical Co., Ltd.’s PE Ratio is greater than MediPal Holdings Corporation (12.54), greater than Sundrug Co.,Ltd. (14.29), greater than COSMOS Pharmaceutical Corporation (15.57), greater than Suzuken Co., Ltd. (8.99), greater than Sugi Holdings Co.,Ltd. (11.85), greater than Alfresa Holdings Corporation (9.65), less than Hisamitsu Pharmaceutical Co., Inc. (22.30), greater than Toho Holdings Co., Ltd. (15.37), greater than Kissei Pharmaceutical Co., Ltd. (11.96), less than Kusuri No Aoki Holdings Co., Ltd. (18.96),

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (4536.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (4536.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Santen Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Santen Pharmaceutical Co., Ltd. (4536.T)?

What is the highest PE Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?

What is the 3-year average PE Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?

What is the 5-year average PE Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?

How does the current PE Ratio for Santen Pharmaceutical Co., Ltd. (4536.T) compare to its historical average?